NM_001101426.4:c.55A>C

Variant summary

Our verdict is Likely benign.
-5 Likely Benign
-7
-6
-1
0
+5
+6
+9
+10
B
LB
VUS
LP
P
The variant received -5 classification points (ACGS-UK Somatic Oncogenicity v2025). B1_StrongB3_Supporting

The NM_001101426.4(CRPPA):c.55A>C (p.Ser19Arg) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a cumulative frequency of 0.304 (AC=394,087) in the gnomAD database across 1,297,340 control chromosomes, including 60,694 homozygotes. The grpmax filtering allele frequency (95% CI) is 0.378. In-silico predictor (REVEL) classifies this variant as likely benign. Splicing prediction tools (SpliceAI) predict no significant impact on normal splicing. Variant has been reported in ClinVar as Benign/Likely Benign (★★). The variant has been observed in cBioPortal in 1 sample across 1 study and 1 cancer type; somatic enrichment level: NONE (Observed in at most one deduplicated cBioPortal case.). This exact variant is curated in the UniProt human variants database as Uncertain Significance; it is also listed as a COSMIC curated somatic variant.

Frequency

Genomes: 𝑓 0.30 ( 6867 hom., cov: 33)
Exomes 𝑓: 0.30 ( 53827 hom. )

Consequence

CRPPA
NM_001101426.4 missense

Scores

1
17

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:11

Conservation

PhyloP100: -1.69

Publications

16 publications found
Variant links:
Genes affected
CRPPA (HGNC:37276): (CDP-L-ribitol pyrophosphorylase A) This gene encodes a 2-C-methyl-D-erythritol 4-phosphate cytidylyltransferase-like protein. Mutations in this gene are the cause of Walker-Warburg syndrome. Alternate splicing results in multiple transcript variants. [provided by RefSeq, May 2012]
CRPPA Gene-Disease associations (from GenCC):
  • muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A, 7
    Inheritance: AR Classification: DEFINITIVE, STRONG Submitted by: Labcorp Genetics (formerly Invitae), G2P, Genomics England PanelApp
  • myopathy caused by variation in CRPPA
    Inheritance: AR Classification: DEFINITIVE, STRONG Submitted by: PanelApp Australia, ClinGen
  • autosomal recessive limb-girdle muscular dystrophy type 2U
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
  • congenital muscular dystrophy without intellectual disability
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
  • muscular dystrophy-dystroglycanopathy, type A
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

new If you want to explore the variant's impact on the transcript NM_001101426.4, check out the Mutation Effect Viewer. This is especially useful for frameshift variants or if you want to visualize the effect of exon loss / intron retention.

Classification according to ACGS-UK Somatic Oncogenicity v2025

Classification was made for transcript:

Our verdict: Likely_benign. The variant received -5 points.

B1High frequency in general population
GnomAD effective popmax AF >1% — B1 stand-alone benign; GnomAD effective popmax AF = 0.378 — exceeds 1% threshold (B1 applied)
B3Computational evidence does not support deleterious effect
Computational evidence does not support a deleterious effect; Missense variant — primary computational scorer does not support an oncogenic/deleterious effect; supports B3

Variant Effect in Transcripts

Automated classification analysis was done for transcript: NM_001101426.4. You can select a different transcript below to see updated classification assignments.

RefSeq Transcripts

CRPPA NM_001101426.4
MANE Select
HGVSc / HGVSpc.55A>Cp.Ser19Arg
Exon rankExon 1 of 10
missense
Prot: NP_001094896.1UniProt: A4D126-1
CRPPA NM_001368197.1
HGVSc / HGVSpc.55A>Cp.Ser19Arg
Exon rankExon 1 of 9
missense
Prot: NP_001355126.1
CRPPA NM_001101417.4
HGVSc / HGVSpc.55A>Cp.Ser19Arg
Exon rankExon 1 of 9
missense
Prot: NP_001094887.1UniProt: A0A140VJM1A4D126-2

Ensembl Transcripts

CRPPA ENST00000407010.7
TSL:5MANE Select
HGVSc / HGVSpc.55A>Cp.Ser19Arg
Exon rankExon 1 of 10
missense
Prot: ENSP00000385478.2UniProt: A4D126-1
CRPPA ENST00000399310.3
TSL:1
HGVSc / HGVSpc.55A>Cp.Ser19Arg
Exon rankExon 1 of 9
missense
Prot: ENSP00000382249.3UniProt: A4D126-2
CRPPA ENST00000856526.1
HGVSc / HGVSpc.55A>Cp.Ser19Arg
Exon rankExon 1 of 8
missense
Prot: ENSP00000526585.1UniProt: A0ACI8QS87

Frequencies

Allele frequencies (AF), counts (AC/AN), homozygotes and coverage

Common (AF > 0.05 / Hom > 5)
Rare (AF ≤ 0.0001 / Hom ≤ 1)
Global population databases 6 sources
GnomAD3 genomes
AF: 0.299
AC:45300
Hom:6873
AN:151428
Cov:33
GnomAD2 exomes
AF: 0.257
AC:3585
AN:13926
GnomAD4 exome
AF: 0.304
AC:348776
Hom:53827
AN:1145802
Cov:34
GnomAD4 genome
AF: 0.299
AC:45311
Hom:6867
AN:151538
Cov:33
TOPMed (Bravo)
AF: 0.296
ALFA (dbGaP/dbSNP Allele Frequency Aggregator)
AF: 0.212
AC:7251
Hom:1070
AN:34150
Local & regional cohorts 10 sources
ABraOM SABE-WGS-1171
AF: 0.291
AC:682
Hom:92
AN:2342
ChinaMAP Phase 1
AF: 0.304
Denmark Genome
AF: 0.317
AC:95
AN:300
GenomeAsia100K
AF: 0.337
AC:1170
AN:3464
Korea4K (4,157 Koreans)
AF: 0.275
AC:1972
AN:7174
Qatari Genome
AF: 0.295
AC:52
AN:176
ToMMo 61KJPN (+60KJPN MNV)
AF: 0.277
AC:33747
Hom:4753
AN:121754
Turkish Variome
AF: 0.276
AC:426
Hom:66
AN:1546
UK10K
AF: 0.318
AC:2406
AN:7562
WBBC (Westlake BioBank for Chinese) pilot
AF: 0.292
AC:2618
Hom:372
AN:8960
Showing 16 sources

Case/control cohorts

CohortCasesControls
AFACANAFACAN
SCHEMA
(Schizophrenia)
0.330 39170118816 0.346 62020179310
Showing 1 cohortAllele count / allele number. AF is computed from the counts for ASC (not provided by the source).

ClinVar

ClinVar submissions
Significance:Benign
Revision:criteria provided, multiple submitters, no conflicts
View on ClinVar
Pathogenic
VUS
Benign
Condition
-
-
7
not specified (7)
-
-
1
Congenital Muscular Dystrophy, alpha-dystroglycan related (1)
-
-
1
Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A, 7 (1)
-
-
1
Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A, 7;C5190987:Autosomal recessive limb-girdle muscular dystrophy type 2U (1)
-
-
1
not provided (1)

Computational Scores

AlphaGenome AVI
Benign5.2
AlphaMissense
Benign0.095
BayesDel_addAF
Benign-0.59T
BayesDel_noAF
Benign-0.47
CADD
Benign3.4
DANN
Benign0.79
DEOGEN2
Benign0.0014T
Eigen
Benign-1.3
Eigen_PC
Benign-1.4
FATHMM_MKL
Benign0.062N
FuncVEP CTI
Benign0.0019
GPN-Star LLR
N/A-1.1
GPN-Star score
N/A1.1
LIST_S2
Benign0.48T
MetaRNN
Benign0.0037T
MetaSVM
Benign-1.1T
Mutation Taster
N/A100/0polymorphism (auto)
MutationAssessor
Benign0.0N
PhyloP100
Benign-1.7
popEVE
Benign-3.0
PrimateAI
Uncertain0.75T
PromoterAI
N/A0.12Neutral
PROVEAN
Benign-0.20N
REVEL
Benign0.14
Sift
Benign0.88T
Sift4G
Benign0.66T
Varity_R
N/A0.046
VESM-3B
Benign-2.4
Showing 28 of 28 scores

Splicing Scores

Pangolin (max)
Benign0.0
SpliceAI score (max)
Benign0.0
Details are displayed if max score is > 0.2
Showing 2 of 2 scores

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

MaxEntScan Visualizer can be used to analyze the impact of this mutation on the neighboring sequence.

MaveDB functional evidence

MaveDB is a public repository of laboratory assays that test the effect of thousands of variants at once — treat this as supporting research data and interpret it with great caution; it is not a clinical classification.

No MaveDB functional evidence found for this variant.

Publications

Other links and lift over

For research and educational, non-commercial use only. Not for clinical or diagnostic use. GeneBe does not provide medical advice. Data use for AI modeling is prohibited: if used, the cost is $0.001 per byte of downloaded uncompressed data.